Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 11, 2006, Pages 1474-1479

  Kojima, Ariko ^a   Ohno Matsui, Kyoko ^a   Teramukai, Satoshi ^b   Ishihara, Yoko ^c   Shimada, Noriaki ^a   Yoshida, Takeshi ^a   Sugamoto, Yoshiharu ^a   Tokoro, Takashi ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Choroidal neovascularization; Multiple regression analysis; Pathologic myopia; Visual outcome

Indexed keywords

ADULT; AGE; ARTICLE; CHOROID DISEASE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE REGRESSION; MYOPIA; OUTCOMES RESEARCH; PHOTODYNAMIC THERAPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REFRACTION ERROR; REGRESSION ANALYSIS; RETINA FOVEA; RETINA HEMORRHAGE; RETINA NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOPIA, DEGENERATIVE; PROGNOSIS; VISUAL ACUITY;

EID: 33750969046     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0324-4     Document Type: Article

References (23)

1. Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schpens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91: 1573-1581
2. Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M (2004) Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: Visual outcome in relation to age at treatment. Am J Ophthalmol 138: 602-607
3. Curtin BJ, Karlin DB (1971) Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 71: 42-50
4. Curtin BJ (1985) Basic science and clinical management. In: The myopias. Harper & Row, Philadelphia, pp 237-245
5. Ergun E, Heinzl H, Stur M (2004) Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 138: 434-438
6. Hampton GR, Kohen D, Bird AC (1983) Visual prognosis of disciform degeneration in myopia. Ophthalmology 90: 923-926
7. Hayashi K, Ohno-Matsui K, Yoshida T, Kobayashi K, Kojima A, Shimada N, Yasuzumi K, Futagami S, Tokoro T, Mochizuki M (2005) Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefe's Arch Clin Exp Ophthalmol 243: 13-19
8. Hotchkiss ML, Fine SL (1981) Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91: 177-183
9. Kayazawa F, Tamura S, Tsuji T, Matsuda T, Kuwayama W, Machida T (1983) The influence of aging on vitreous fluorophotometry. J Jpn Ophthalmol Soc 87: 380-383
10. Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong K (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes: A prospective series of 1 and 2 year follow up. Br J Ophthalmol 88: 1315-1319
11. Montero JA, Ruiz-Moreno JM (2005) Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularization. Br J Ophthalmol 87: 173-176
12. Riise R (1988) Myopia as a cause of blindness. Acta Ophthalmol (Suppl) 185: 109-110
13. Secreran M, Kuhn D, Soubrane G, Coscas G (1997) Long-term visual outcome of choroidal neovascularization in pathologic myopia: Natural history and laser treatment. Eur J Ophthalmol 7: 307-316
14. Sperduto RD, Seigel D, Roberts J, Rowland M (1983) Prevalence of myopia in the United States. Arch Ophthalmol 101: 405-407
15. Steidl SM, Pruett RC (1997) Macular complications associated with posterior staphyloma. Am J Ophthalmol 123: 181-187
16. Tabandeh H, Flynn HW, Scott IU, Lewis ML, Rosenfeld PJ, Rodriguez F, Rodriguez A, Singerman LJ, Schiffman J (1999) Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 106: 2063-2067
17. Tano Y (2002) Pathologic myopia: Where are we now? Am J Ophthalmol 134: 645-660
18. Terasaki H, Ishikawa K, Suzuki T, Nakamura M, Miyake K, Miyake Y (2003) Morphologic and angiographic assessment of the macula after macular translocation surgery with 360 degrees retinotomy. Ophthalmology 110: 2403-2408
19. Tokoro T (1988) On the definition of pathologic myopia in group studies. Acta Ophthalmol 66: 107-108
20. Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia. 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 110: 667-673
21. Yoshida A, Murakami K, Kojima M (1986) Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. Alteration of the inward permeability of the blood-retinal barrier and the diffusion coefficient of fluorescein in the vitreous with aging in normal subjects. J Jpn Ophthalmol Soc 90: 589-594
22. Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M (2002) Long-term visual prognosis of choroidal neovascularization in high myopia. Ophthalmology 109: 712-719
23. Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T, Mochizuki M (2003) Myopic choroidal neovascularization: A 10-year follow-up. Ophthalmology 110: 1297-1305